Biomarker analysis of S-1 in SELECT-BC: A randomized phase III study of taxane versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT-BC EURECA)

Authors :: Hiromitsu Akabane
Takanori Watanabe
Daisuke Yotsumoto
Naruto Taira
Junji Tsurutani
Tsutomu Takashima
Ken-ichi Watanabe
Fumikata Hara
Shozo Ohsumi
Reiki Nishimura
Yasuo Ohashi
Yasuo Hozumi
Tsuyoshi Saito
Tatsuya Toyama
Yukari Uemura
Hirofumi Mukai
Source :: Journal of Clinical Oncology. 34:e23274-e23274
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e23274Background: S-1 is oral fluoropyrimidine which is a biochemically modulated drug to increase 5-FU concentration and to avoid gastrointestinal toxicities. SELECT-BC, a randomized phase III tri...

Subjects :: Drug
Oncology
Cancer Research
medicine.medical_specialty
Taxane
business.industry
media_common.quotation_subject
medicine.disease
Metastatic breast cancer
Internal medicine
medicine
Biomarker Analysis
First line chemotherapy
business
media_common

Tools